Nanosonics Limited (NNCSF)
USD 1.75
(0.0%)
USD 1.75
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | 9.11 Million AUD | -49.35% |
| 2023 | 17.99 Million AUD | 2172.6% |
| 2022 | 792 Thousand AUD | -90.55% |
| 2021 | 8.38 Million AUD | -28.12% |
| 2020 | 11.65 Million AUD | -12.83% |
| 2019 | 13.37 Million AUD | 400.75% |
| 2018 | 2.67 Million AUD | -77.97% |
| 2017 | 12.12 Million AUD | 2418.36% |
| 2016 | -523 Thousand AUD | 92.29% |
| 2015 | -6.78 Million AUD | -140.53% |
| 2014 | -2.82 Million AUD | 56.01% |
| 2013 | -6.41 Million AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 FY | 8.38 Million AUD | -53.41% |
| 2024 Q4 | 3.04 Million AUD | 0.0% |
| 2024 Q1 | 1.71 Million AUD | -78.36% |
| 2024 Q2 | 3.62 Million AUD | 111.48% |
| 2024 Q3 | 3.04 Million AUD | -16.07% |
| 2023 Q2 | 10.07 Million AUD | 92.07% |
| 2023 Q4 | 7.92 Million AUD | 117.0% |
| 2023 Q1 | 5.24 Million AUD | 426.49% |
| 2023 FY | 17.99 Million AUD | 2172.6% |
| 2023 Q3 | 3.65 Million AUD | -63.72% |
| 2022 Q2 | 2.39 Million AUD | 25.25% |
| 2022 Q4 | -1.6 Million AUD | -61.57% |
| 2022 FY | 792 Thousand AUD | -90.55% |
| 2022 Q1 | 1.91 Million AUD | -73.43% |
| 2022 Q3 | -994 Thousand AUD | -141.45% |
| 2021 FY | 8.38 Million AUD | -28.12% |
| 2021 Q3 | 4.26 Million AUD | 264.87% |
| 2021 Q4 | 7.2 Million AUD | 68.8% |
| 2021 Q1 | 621.5 Thousand AUD | -90.67% |
| 2021 Q2 | 1.17 Million AUD | 88.25% |
| 2020 Q4 | 6.66 Million AUD | 99.79% |
| 2020 FY | 11.65 Million AUD | -12.83% |
| 2020 Q1 | 2.83 Million AUD | 23.34% |
| 2020 Q2 | 5.66 Million AUD | 99.89% |
| 2020 Q3 | 3.33 Million AUD | -41.16% |
| 2019 Q4 | 2.29 Million AUD | 0.0% |
| 2019 Q1 | 4.53 Million AUD | 2741.98% |
| 2019 Q2 | 4.53 Million AUD | 0.0% |
| 2019 Q3 | 2.29 Million AUD | -49.26% |
| 2019 FY | 13.37 Million AUD | 400.75% |
| 2018 Q3 | -171.5 Thousand AUD | -110.87% |
| 2018 FY | 2.67 Million AUD | -77.97% |
| 2018 Q1 | 1.57 Million AUD | -20.28% |
| 2018 Q2 | 1.57 Million AUD | 0.0% |
| 2018 Q4 | -171.5 Thousand AUD | 0.0% |
| 2017 Q1 | 4.58 Million AUD | 173.92% |
| 2017 Q4 | 1.97 Million AUD | 0.0% |
| 2017 FY | 12.12 Million AUD | 2418.36% |
| 2017 Q3 | 1.97 Million AUD | -56.83% |
| 2017 Q2 | 4.58 Million AUD | 0.0% |
| 2016 Q1 | -1.85 Million AUD | 49.65% |
| 2016 Q4 | 1.67 Million AUD | 0.0% |
| 2016 Q3 | 1.67 Million AUD | 190.05% |
| 2016 Q2 | -1.85 Million AUD | 0.0% |
| 2016 FY | -523 Thousand AUD | 92.29% |
| 2015 Q1 | 301 Thousand AUD | -20.79% |
| 2015 FY | -6.78 Million AUD | -140.53% |
| 2015 Q4 | -3.69 Million AUD | 0.0% |
| 2015 Q3 | -3.69 Million AUD | -1326.74% |
| 2015 Q2 | 301 Thousand AUD | 0.0% |
| 2014 Q2 | -1.79 Million AUD | 0.0% |
| 2014 Q4 | 380 Thousand AUD | 0.0% |
| 2014 Q3 | 380 Thousand AUD | 121.23% |
| 2014 Q1 | -1.79 Million AUD | -14420.0% |
| 2014 FY | -2.82 Million AUD | 56.01% |
| 2013 Q3 | 12.5 Thousand AUD | 100.39% |
| 2013 FY | -6.41 Million AUD | 0.0% |
| 2013 Q1 | -3.21 Million AUD | 0.0% |
| 2013 Q2 | -3.21 Million AUD | 0.0% |
| 2013 Q4 | 12.5 Thousand AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.16 Million USD | -683.099% |
| Ansell Limited | 129.3 Million USD | 92.949% |
| Ansell Limited | 129.3 Million USD | 92.949% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 31.13 Million USD | 70.721% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.59 Million USD | 671.348% |
| Psykey, Inc. | -797.5 Thousand USD | 1243.192% |
| ConvaTec Group Plc | 262.7 Million USD | 96.53% |
| ConvaTec Group Plc | 262.7 Million USD | 96.53% |
| Encision Inc. | -640.78 Thousand USD | 1522.791% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 6529.025% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | 8393.459% |
| Innovative MedTech Inc. | -4.27 Million USD | 313.309% |
| LifePoint, Inc. | -7.49 Million USD | 221.637% |
| Medite Cancer Diagnostics, Inc. | -6.48 Million USD | 240.694% |
| Paradigm Medical Industries, Inc. | 330 Thousand USD | -2662.727% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -122.89 Thousand USD | 7518.83% |
| Reflect Scientific, Inc. | -467.27 Thousand USD | 2051.087% |
| SmileDirectClub, Inc. | -241.15 Million USD | 103.781% |
| Sector 10, Inc. | -39.84 Thousand USD | 22981.739% |
| Shandong Weigao Group Medical Polymer Company Limited | 319.6 Million USD | 97.147% |
| SheerVision, Inc. | 155.72 Thousand USD | -5754.514% |
| United Health Products, Inc. | -2.42 Million USD | 475.72% |
| Vasamed, Inc. | 4.74 Million USD | -92.248% |
| Wearable Health Solutions, Inc. | -2.29 Million USD | 497.404% |
| Yubo International Biotech Limited | -1.2 Million USD | 856.458% |